Menu UF Health Home Menu

Richard Segal, Ph.D.

Richard Segal

Professor and Dr. Robert and Barbara Crisafi Chair in Pharmaceutical Outcomes and Policy

Pharmaceutical Outcomes and Policy

OFFICE: HPNP Room 3333


PHONE: 352-273-6265

CV: Link to CV



  • B.S. Pharmacy, University of Connecticut
  • M.S. Hospital and Clinical Pharmacy, University of Iowa
  • Ph.D. Pharmaceutical Outcomes Research, Virginia Commonwealth University
  • Residency, Mayo Graduate School

Biographical Sketch

Richard Segal, Ph.D., is a professor and Chair of Pharmaceutical Outcomes & Policy at the University of Florida College of Pharmacy. He also holds faculty appointments in the college’s Department of Pharmacotherapy and Translational Research, and in the UF College of Public Health and Health Professions. His research interests include disease management and outcomes research particularly in the areas of drug prescribing, pharmaceutical care, and medication therapy management.

Segal is widely recognized for his work in explaining why clinical practice is so often inconsistent with evidence-based best practices. His research in the area of changing prescribing behavior has been the basis of prescribing interventions throughout the world. Segal was Co-PI on the first major research project focused on training community pharmacists to identify and prevent drug related problems which contribute to preventable drug related morbidity called Therapeutic Outcomes Monitoring (TOM). Their research has helped to shape many medication therapy management interventions used by Medicare Part D prescription drug plans.

Segal has extensive experience in Medicaid data analysis and studying the impact of interventions such as formulary changes, physician profiling, and provider/patient education. Segal also works closely with technology changeds such as Barode Medication Administration, the College of Pharmacy’s MTM Call Center, and is seeing ways to improve patient participation rate in  MTM services and also in improving physician’s acceptance of drug therapy recommendations. Segal is also collaborating on a series of initiatives with Professor Folake Odedina in addressing health disparities in prostate cancer.


Professor and Chair, Department of Pharmaceutical Outcomes & Policy, College of Pharmacy
Professor, Department of Pharmacotherapy and Translational Research
Professor, Health Services Research, Management, and Policy, College of Public Health
Member, Florida Center for Medicaid and the Uninsured
Member, Shands Cancer Center

Recent Publications

Hepler CD and Segal R.  Preventing medication errors and improving drug therapy outcomes: A management systems approach. Boca Raton FL:  CRC Press, 2003, 520 pages, ISBN: 0-8493-1576-X.

Maue S, Segal R, Kimberlin C, Lipowski EE.  Predicting physician guideline compliance:  An assessment of motivators and perceived barriers.  Am J Managed Care 2004, 10: 383-391.

Robinson JD, Segal R, Lopez LM, Doty RE.   Impact of a Pharmaceutical Care Intervention on Blood Pressure Control in a Chain Pharmacy Practice.  Annals of Pharmacotherapy, 2010; 44:88-96.

Wen S, Meador KJ, Loring DW, Eisenschenk S, Segal R, Hartzema A.  Is Antiepileptic Drug Use Related to Depression and Suicidality Among Patients with Epilepsy? Epilepsy and Behavior 2010 (in press).

Planes, LG, Kimberlin CL, Segal R, Brushwood DB, Hepler CD, Schlenker BR.   A pharmacist model of perceived responsibility for drug therapy outcomes.   Social Science & Medicine 2005, 60: 2393–2403.